Bulletin Contents
Search
Home Page
 
Vaxil Bio Ltd. 
Listed Company 

VAXIL BIO LTD. ("VXL")
[formerly Emerge Resources Corp. ("EME")]
BULLETIN TYPE: Reverse Takeover-Completed, Private Placement-Brokered, Name Change and Consolidation, Symbol Change, Resume Trading
BULLETIN DATE: March 9, 2016
TSX Venture Tier 2 Company

TSX Venture Exchange Inc. (the "Exchange") has accepted for filing Emerge Resources Corp. (the "Company" - now "Vaxil Bio Ltd.") Reverse Takeover (the "RTO") and related transactions, all as principally described in its information circular dated November 30, 2015 (the "Circular"). The RTO includes the following matters, all of which have been accepted by the Exchange.

Reverse Takeover-Completed
Pursuant to a share exchange agreement, dated November 30, 2015, (the "Agreement") among the Company and Vaxil Bio Ltd. ("Vaxil"), a company incorporated under the laws of the State of Israel, the Company issued 25,000,000 (post-consolidated) common shares to securityholders to acquire 100% of the issued capital of Vaxil.
The Exchange has been advised that the RTO and the related transactions, as indicated below, have received approval from shareholders and have been completed. For additional information please refer to the Filing Statement available under the Company's profile on SEDAR and the Company's news release dated February 29, 2016.

Private Placement-Brokered

Pursuant to the RTO, the Exchange has also accepted for filing documentation with respect to a Brokered Private Placement announced May 26, 2015 and further detailed in the November 30, 2015 Circular:

Number of Shares: 11,601,105 shares

Purchase Price: $0.23 per share

Warrants: 11,601,105 share purchase warrants to purchase 11,601,105 shares

Warrant Exercise Price: Each warrant is exercisable for three years. The strike price is $0.31 in year one and $0.36 in years two and three.

Number of Placees: 20 Placees

Insider / Pro Group Participation:


Agent's Fee: $109,060 and $30,000 work fee to M Partners Inc. $100,685 to Sunel Securities Inc. 453,914 broker options to Foremost Capital Corporation and 474,174 broker options to Sunel Securities Inc. The broker options have an exercise price of $0.23 and expire March 9, 2019.

Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company must issue a news release announcing the closing of the private placement and setting out the expiry dates of the hold period(s). The Company must also issue a news release if the private placement does not close promptly. Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.
Name Change and Consolidation, Symbol Change and Resume Trading

Pursuant to a resolution passed by shareholders on January 8, 2016, the Company has consolidated its capital on a two (2) old for one (1) new basis. The name of the Company has also been changed as follows.

Effective at the opening on Thursday, March 10, 2016, the common shares of Vaxil Bio Ltd. will commence trading on TSX Venture Exchange Inc., and the common shares of Emerge Resources Corp. will be delisted. The Company is classified as a 'Life Sciences' company.

Post - Consolidation
Capitalization: Unlimited shares with no par value of which
46,439,152 shares are issued and outstanding
Escrow: 3,859,200 shares subject to Tier 2 Value Escrow

Transfer Agent: Computershare Trust Company of Canada
Trading Symbol: VXL (new)
CUSIP Number: 92243L 10 7 (new)
________________________________________